TFX · XBRL financial data

Teleflex financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (TFX's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	2,537	2,810	2,791	2,974	3,047	1,993
Cost of goods and services sold	1,212	1,260	1,260	1,328	1,345	872
Gross profit	1,325	1,550	1,531	1,647	1,703	1,121
Research and development	120	131	154	154	162	145
Selling, general and administrative	744	860	864	930	995	720
Operating income (loss)	423	628	500	506	151	118
Interest income	1	1	1	13	8	6
Interest expense	66	57	54	85	84	100
Income tax expense (benefit)	22	74	83	76	5	(34)
Net income (loss)	335	485	363	356	70	(906)
Earnings per share, basic USD per share	7.21	10.38	7.74	7.58	1.49	(20.30)
Earnings per share, diluted USD per share	7.09	10.23	7.68	7.53	1.48	(20.25)
Weighted average shares, basic millions of shares	46	47	47	47	47	45
Weighted average shares, diluted millions of shares	47	47	47	47	47	45

Fiscal years (TFX's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	376	445	292	223	290	379
Accounts receivable	395	384	409	443	459	346
Inventory	513	478	579	626	600	404
Prepaid and other current assets	115	117	125	107	118	151
Total current assets	1,422	1,429	1,411	1,407	1,471	1,938
Property and equipment, net	474	444	447	480	503	498
Right-of-use asset	101	130	131	124	109	92
Goodwill	2,586	2,504	2,537	2,914	2,632	2,305
Total assets	7,153	6,872	6,928	7,533	7,098	6,947
Accounts payable	103	118	127	132	141	130
Accrued liabilities	136	163	141	147	143	117
Current portion of long-term debt	101	110	88	88	100	100
Total current liabilities	540	680	581	607	649	762
Long-term debt	2,378	1,740	1,624	1,728	1,556	2,541
Lease liability, non-current	86	116	120	111	99	84
Total liabilities	3,816	3,117	2,906	3,092	2,820	3,822
Retained earnings	3,096	3,518	3,817	4,110	4,116	3,150
Total stockholders' equity	3,336	3,755	4,022	4,441	4,278	3,125
Total liabilities and equity	7,153	6,872	6,928	7,533	7,098	6,947
Common shares outstanding (cover page) millions of shares	47	47	47	47	46	44

Fiscal years (TFX's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	335	485	363	356	70	(906)
Stock-based compensation	21	23	27	31	31	26
Purchases of property and equipment	91	72	79	91	126	95
Net cash from investing activities	(838)	157	—	—	—	—
Share repurchases	—	—	0	0	200	300
Dividends paid	63	64	64	64	64	60
Proceeds from long-term debt	1,514	400	744	646	130	1,140
Repayments of long-term debt	939	1,035	885	545	292	153
Net cash from financing activities	455	(716)	(218)	39	(422)	612
Net change in cash	75	69	(153)	(69)	105	126

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Teleflex	300	570	not reported	42.4M	—	Q2 FY26 10-QJun 30, 2026
Haemonetics	223	339	52	45.5M	—	Q1 FY27 10-QJun 27, 2026
LivaNova	563	393	not reported	55.1M	—	Q3 FY26 10-QSep 30, 2026
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
Enovis	13	583	75*	57.7M	—	Q2 FY26 10-QJul 3, 2026
Ufp Technologies	9	174	16*	7.7M	—	Q2 FY26 10-QJun 30, 2026
Lemaitre Vascular	27	not reported	16*	22.9M	—	Q2 FY26 10-QJun 30, 2026
Dentsply Sirona	239	898	99*	199.4M	—	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	228	94	(19)*	57.3M	11.8 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.